Publications

Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.

BHASKARAN, K; RENTSCH, CT; Hickman, G; Hulme, WJ; SCHULTZE, A; Curtis, HJ; WING, K; WARREN-GASH, C; TOMLINSON, L; Bates, CJ; MATHUR, R; MacKenna, B; MAHALINGASIVAM, V; WONG, A; Walker, AJ; Morton, CE; GRINT, D; Mehrkar, A; EGGO, RM; Inglesby, P; DOUGLAS, IJ; MCDONALD, HI; Cockburn, J; WILLIAMSON, EJ; Evans, D; ... GOLDACRE, B.

2022

PLoS medicine, (2022).19 1 10.1371/journal.pmed.1003871.

Updating age-specific contact structures to match evolving demography in a dynamic mathematical model of tuberculosis vaccination.

WEERASURIYA, CK; Harris, RC; MCQUAID, CF; Gomez, GB; WHITE, RG;

2022

PLoS Computational Biology, (2022).18 4 10.1371/journal.pcbi.1010002.

Inferring risks of coronavirus transmission from community household data.

House, T; Riley, H; Pellis, L; Pouwels, KB; Bacon, S; Eidukas, A; Jahanshahi, K; EGGO, RM; Sarah Walker, A;

2022

Statistical methods in medical research, (2022).31 9 10.1177/09622802211055853.

The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020.

Knight, GM; Pham, TM; Stimson, J; FUNK, S; Jafari, Y; Pople, D; Evans, S; Yin, M; Brown, CS; Bhattacharya, A; Hope, R; Semple, MG; ABBOTT, S; Gimma, A; Gibbs, HP; Abbas, K; Barnard, RC; Sandmann, FG; BOSSE, NI; Mee, P; McCarthy, CV; Quaife, M; KUCHARSKI, AJ; JARVIS, CI; Hellewell, J; ... Robotham, JV.

2022

BMC infectious diseases, (2022).22 1 10.1186/s12879-022-07490-4.

RESIST2: Transmission.

Knight, G;

2022

, London School of Hygiene & Tropical Medicine (2022). 10.17037/PUBS.04669770.

Evaluating and mitigating the potential indirect effect of COVID-19 on control programmes for seven neglected tropical diseases: a modelling study.

Borlase, A; Le Rutte, EA; Castaño, S; Blok, DJ; Toor, J; Giardina, F; Davis, EL; NTD Modelling Consortium,;

2022

The Lancet Global health, (2022).10 11 10.1016/S2214-109X(22)00360-6.

Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptions.

Burger, E; Baussano, I; Kim, JJ; Laprise, J-F; Berkhof, J; Schiller, JT; Canfell, K; PREM, K; Brisson, M; JIT, M; Barnabas, RV;

2022

Vaccine, (2022).41 16 10.1016/j.vaccine.2022.07.022.

Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden.

Gonçalves, BP; PROCTER, SR; PAUL, P; CHANDNA, J; LEWIN, A; Seedat, F; Koukounari, A; Dangor, Z; Leahy, S; Santhanam, S; John, HB; Bramugy, J; Bardají, A; Abubakar, A; Nasambu, C; Libster, R; Sánchez Yanotti, C; Horváth-Puhó, E; Sørensen, HT; Van de Beek, D; Bijlsma, MW; Gardner, WM; Kassebaum, N; Trotter, C; Bassat, Q; ... CHAMPS team,

2022

The Lancet. Global health, (2022).10 6 10.1016/S2214-109X(22)00093-6.

A cluster-randomised, non-inferiority trial of the impact of a two-dose compared to three-dose schedule of pneumococcal conjugate vaccination in rural Gambia: the PVS trial.

MACKENZIE, GA; OSEI, I; Salaudeen, R; Hossain, I; Young, B; Secka, O; D'ALESSANDRO, U; Palmu, AA; Jokinen, J; Hinds, J; FLASCHE, S; Mulholland, K; Nguyen, C; GREENWOOD, B;

2022

Trials, (2022).23 1 10.1186/s13063-021-05964-5.

The impact of alternative delivery strategies for novel tuberculosis vaccines in low- and middle-income countries: a modelling study.

Clark, R; Mukandavire, C; Portnoy, A; WEERASURIYA, C; Deol, A; Scarponi, D; Iskauskas, A; Bakker, R; Quaife, M; Malhotra, S; Gebreselassie, N; Zignol, M; Hutubessy, RC W; Giersing, B; JIT, M; Harris, R; Menzies, N; WHITE, R;

2022

medRxiv (2022). 10.1101/2022.04.16.22273762.